Sawyer & Company’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.84M | Sell |
14,322
-2,135
| -13% | -$250K | 0.62% | 48 |
|
|
2026
Q1 | $1.98M | Sell |
16,457
-945
| -5% | -$109K | 0.76% | 44 |
|
|
2025
Q4 | $1.83M | Buy |
17,402
+618
| +4% | +$58K | 0.65% | 49 |
|
|
2025
Q3 | $1.33M | Buy |
16,784
+2,462
| +17% | +$203K | 0.5% | 54 |
|
|
2025
Q2 | $1.84M | Sell |
14,322
-2,542
| -15% | -$202K | 0.62% | 48 |
|
|
2025
Q1 | $1.51M | Sell |
16,864
-609
| -3% | -$56.9K | 0.61% | 54 |
|
|
2024
Q4 | $1.74M | Sell |
17,473
-1,908
| -10% | -$197K | 0.64% | 50 |
|
|
2024
Q3 | $2.2M | Sell |
19,381
-65
| -0.3% | -$7.72K | 0.81% | 47 |
|
|
2024
Q2 | $2.41M | Buy |
19,446
+554
| +3% | +$71.4K | 0.96% | 41 |
|
|
2024
Q1 | $2.49M | Sell |
18,892
-229
| -1% | -$28.2K | 1% | 42 |
|
|
2023
Q4 | $2.08M | Sell |
19,121
-325
| -2% | -$33.7K | 0.92% | 44 |
|
|
2023
Q3 | $2M | Sell |
19,446
-900
| -4% | -$97K | 0.93% | 42 |
|
|
2023
Q2 | $2.35M | Sell |
20,346
-1,675
| -8% | -$190K | 1.07% | 37 |
|
|
2023
Q1 | $2.48M | Sell |
22,021
-990
| -4% | -$107K | 1.34% | 28 |
|
|
2022
Q4 | $2.55M | Sell |
23,011
-215
| -0.9% | -$22K | 1.26% | 33 |
|
|
2022
Q3 | $2M | Sell |
23,226
-325
| -1% | -$29K | 1.09% | 34 |
|
|
2022
Q2 | $2.15M | Sell |
23,551
-1,294
| -5% | -$115K | 1.09% | 35 |
|
|
2022
Q1 | $2.04M | Sell |
24,845
-1,046
| -4% | -$82.5K | 0.92% | 43 |
|
|
2021
Q4 | $1.98M | Sell |
25,891
-225
| -0.9% | -$17.9K | 0.86% | 43 |
|
|
2021
Q3 | $1.96M | Buy |
26,116
+1,280
| +5% | +$97.3K | 0.93% | 42 |
|
|
2021
Q2 | $1.93M | Sell |
24,836
-1,412
| -5% | -$105K | 0.9% | 43 |
|
|
2021
Q1 | $1.93M | Buy |
26,248
+316
| +1% | +$23.3K | 0.96% | 38 |
|
|
2020
Q4 | $2.02M | Buy |
25,932
+137
| +0.5% | +$10.5K | 1.03% | 34 |
|
|
2020
Q3 | $2.04M | Sell |
25,795
-200
| -0.8% | -$15.7K | 1.21% | 29 |
|
|
2020
Q2 | $1.92M | Buy |
25,995
+226
| +0.9% | +$17K | 1.19% | 28 |
|
|
2020
Q1 | $1.89M | Sell |
25,769
-194
| -0.7% | -$15.2K | 1.51% | 19 |
|
|
2019
Q4 | $2.25M | Buy |
25,963
+728
| +3% | +$59.8K | 1.45% | 17 |
|
|
2019
Q3 | $2.03M | Sell |
25,235
-655
| -3% | -$52.5K | 1.44% | 19 |
|
|
2019
Q2 | $2.07M | Sell |
25,890
-1,074
| -4% | -$82.2K | 1.39% | 20 |
|
|
2019
Q1 | $2.14M | Hold |
26,964
| – | – | 1.4% | 21 |
|
|
2018
Q4 | $1.97M | Sell |
26,964
-445
| -2% | -$31.4K | 1.44% | 23 |
|
|
2018
Q3 | $1.85M | Buy |
27,409
+3,322
| +14% | +$212K | 1.13% | 27 |
|
|
2018
Q2 | $1.4M | Buy |
24,087
+2,321
| +11% | +$131K | 0.91% | 37 |
|
|
2018
Q1 | $1.13M | Buy |
21,766
+383
| +2% | +$20.7K | 0.76% | 48 |
|
|
2017
Q4 | $1.15M | Buy |
+21,383
| New | +$1.19M | 0.75% | 47 |
|
Other funds holding MRK
ECSS
Sawyer & Company's MRK Position: Q2 2026 in Review
Sawyer & Company reduced its Merck (MRK) stake by 13% in Q2 2026, selling an estimated $250K and leaving 14,322 shares worth $1.84M. The position accounts for 0.62% of the portfolio, ranked #48.
Sawyer & Company first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.55M in Q4 2022. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Sawyer & Company held 14,322 shares of Merck worth $1.84M as of Q2 2026.
- Sawyer & Company sold 2,135 Merck shares in Q2 2026, an estimated $250K.
- Merck made up 0.62% of Sawyer & Company's portfolio in Q2 2026, its #48 holding.
- Sawyer & Company first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- Sawyer & Company's Merck position peaked at $2.55M in Q4 2022.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Sawyer & Company's 13F filing for Q2 2026, filed 23 Jul 2026.